NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

A Study of Real-World Characteristics, Treatment Patterns, and Clinical Outcomes in Patients With Metastatic Castration-Resistant Prostate Cancer

NCT07677254

RecruitingN/A

Sponsor: Novartis Pharmaceuticals

Conditions: Prostatic Neoplasms, Castration-Resistant

Countries: United States

The aim of this study is to assess treatment patterns, clinical outcomes, and patient characteristics among adults with metastatic castration-resistant prostate cancer (mCRPC) in the United States (US) real-world clinical practice. This study will be conducted using data extracted from the PRECISION (PRostatE Cancer dISease observatION) data platform.

Eligibility overview

Sex: MALE

Age: 18 Years to 115 Years

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion criteria:

* Diagnosis of mCRPC between 01 January 2021 and 31 December 2025.
* Male sex at index, where index is the date of initial mCRPC diagnosis.
* Age 18 years at index.

Exclusion criteria:

• None

Locations (1)

East Hanover, New Jersey, United States